| Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy (NCT05406206) | Peking University Cancer Hospital & Institute | 2022-02-25 |
| Study of Pembrolizumab and M032 (NSC 733972) (NCT05084430) | University of Alabama at Birmingham | 2022-02-25 |
| Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) (NCT06030544) | Spanish National Research Council | 2022-02-25 |
| Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer (NCT05253066) | Shengjing Hospital | 2022-02-25 |
| Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers (NCT04844528) | University of Utah | 2022-02-25 |
| A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With Gout (NCT05256810) | Alnylam Pharmaceuticals | 2022-02-25 |
| A Study of ES104 in Patients With Metastatic Colorectal Cancer (NCT05167448) | Elpiscience (Suzhou) Biopharma, Ltd. | 2022-02-25 |
| Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors (NCT06425705) | Lahore General Hospital | 2022-02-25 |
| Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer (NCT04992780) | University of Kansas Medical Center | 2022-02-25 |
| A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC (NCT05945368) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-02-25 |
| A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV (NCT05005078) | WinSanTor, Inc | 2022-02-24 |
| Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease (NCT04771416) | Gemma Biotherapeutics | 2022-02-24 |
| An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study (NCT05360576) | Lupin Research Inc | 2022-02-24 |
| Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC (NCT05254847) | Fudan University | 2022-02-24 |
| Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain (NCT05196919) | Xalud Therapeutics, Inc. | 2022-02-24 |
| Probiotics, Immune Function, and the Brain in Alcohol Consumers (NCT05232682) | Brown University | 2022-02-24 |
| Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B (NCT05256823) | Lai Wei | 2022-02-24 |
| A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects (NCT04985721) | Peter MacCallum Cancer Centre, Australia | 2022-02-24 |
| Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis (NCT05182034) | Medipost Co Ltd. | 2022-02-24 |
| A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients (NCT05197556) | Glaceum | 2022-02-24 |
| Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy (NCT05180006) | Gustave Roussy, Cancer Campus, Grand Paris | 2022-02-24 |
| Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC) (NCT05233332) | Shanghai Kechow Pharma, Inc. | 2022-02-24 |
| COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS) (NCT05250596) | Azienda USL Toscana Centro | 2022-02-24 |
| A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling (NCT04773782) | Blueprint Medicines Corporation | 2022-02-24 |
| A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. (NCT05288504) | Avalo Therapeutics, Inc. | 2022-02-24 |
| Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders (NCT05064319) | Medical University of South Carolina | 2022-02-24 |
| Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE) (NCT05430802) | Tang-Du Hospital | 2022-02-24 |
| A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy (NCT05398653) | Beijing Mabworks Biotech Co., Ltd. | 2022-02-24 |
| Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization (NCT04879940) | H. Lee Moffitt Cancer Center and Research Institute | 2022-02-23 |
| Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol (NCT05260359) | dsm-firmenich Switzerland AG | 2022-02-23 |
| Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia (NCT05240976) | China Medical University Hospital | 2022-02-23 |
| Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213 (NCT05305989) | Kadmon, a Sanofi Company | 2022-02-23 |
| Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream (NCT05220293) | Oticara Australia PTY LTD | 2022-02-23 |
| Diabetes Homeless Medication Support (NCT05258630) | Hennepin Healthcare Research Institute | 2022-02-23 |
| A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer (NCT04883281) | University of Texas Southwestern Medical Center | 2022-02-23 |
| Umbilical Cord Blood Cell (MC001) Transplant Into Injured Spinal Cord Followed by the Locomotor Training (NCT03979742) | StemCyte, Inc. | 2022-02-22 |
| Efficacy of Simvastatin in Alcoholic Liver Fibrosis (NCT04971577) | Anna Cruceta | 2022-02-22 |
| Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers (NCT04943445) | Latin American Cooperative Oncology Group | 2022-02-22 |
| Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127) (NCT04665037) | Merck Sharp & Dohme LLC | 2022-02-22 |
| Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer (NCT04575961) | North Eastern German Society of Gynaecological Oncology | 2022-02-22 |
| Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee (NCT04992624) | Steven E Harte, PhD | 2022-02-22 |
| Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness (NCT05303376) | Immune Biosolutions Inc | 2022-02-22 |
| Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function (NCT05001269) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2022-02-22 |
| RAE (Realize, Analyze, Engage) (NCT05227339) | ContinueYou, LLC | 2022-02-22 |
| A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus (NCT05110846) | Carmot Therapeutics, Inc. | 2022-02-22 |
| Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis (NCT05197842) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2022-02-22 |
| Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M) (NCT06400264) | National Cancer Institute (NCI) | 2022-02-22 |
| Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults (NCT05266456) | Vaxcyte, Inc. | 2022-02-22 |
| Trial to Study the Efficacy and Safety of BEJO Red Ginger in COVID-19 Patients With Mild Symptoms (NCT05277155) | Research Center for Chemistry, National Research and Innovation Agency of Indonesia | 2022-02-22 |
| Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors (NCT05963386) | The First Affiliated Hospital of Xiamen University | 2022-02-22 |
| Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease (NCT05049525) | Montreal Heart Institute | 2022-02-22 |
| Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease (NCT05214287) | Radboud University Medical Center | 2022-02-22 |
| A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer (NCT05376722) | Hongqian Guo | 2022-02-22 |
| Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma (NCT05002816) | Yale University | 2022-02-21 |
| HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose (NCT05136885) | Merit E. Cudkowicz, MD | 2022-02-21 |
| Extended Cold Stored Apheresis Platelets in Cardiac Surgery Patients (NCT05220787) | Moritz Stolla, MD | 2022-02-21 |
| Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD) (NCT05203341) | Neurocrine Biosciences | 2022-02-21 |
| Effects of Ghrelin Administration on Dopamine and Effort (NCT05318924) | University Hospital Tuebingen | 2022-02-21 |
| LMN-101 in a Campylobacter Human Challenge Model (NCT04182490) | Lumen Bioscience, Inc. | 2022-02-21 |
| A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia (NCT05232149) | Beijing InnoCare Pharma Tech Co., Ltd. | 2022-02-21 |
| Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid (NCT05263505) | Washington University School of Medicine | 2022-02-21 |
| Intrathecal Pemetrexed for Leptomeningeal Metastasis (NCT05289908) | The First Hospital of Jilin University | 2022-02-21 |
| Synbiotic Compound to Reduce Symptoms of Schizophrenia (NCT04226898) | Sheppard Pratt Health System | 2022-02-21 |
| Setrusumab vs Placebo for Osteogenesis Imperfecta (NCT05125809) | Ultragenyx Pharmaceutical Inc | 2022-02-21 |
| The Preventive Effectiveness of the Individualized Jade Wind-Barrier Herbal Tea Bag on the Common Cold in Elderly With Qi-deficiency Constitution (CCJWBT): A Pragmatic Randomized Controlled Trial (NCT05640570) | Hong Kong Baptist University | 2022-02-21 |
| Photobiomodulation on the Salivary Glands of Patients With Xerostomia Induced by the Use of Benzodiazepines (NCT05443022) | University of Nove de Julho | 2022-02-20 |
| Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula (NCT05116072) | University Hospital, Lille | 2022-02-20 |
| Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer (NCT05255523) | Fujian Medical University Union Hospital | 2022-02-20 |
| AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC (NCT05247684) | Akeso | 2022-02-20 |
| Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults (NCT05258669) | Ocugen | 2022-02-20 |
| Postoperative Analgesic Effectiveness of Bupivacaine With and Without Dexmedetomidine in Patients With Abdominal Surgery (NCT06531603) | Sahiwal medical college sahiwal | 2022-02-20 |
| An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC (NCT05252091) | Henan Cancer Hospital | 2022-02-20 |
| Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream (NCT05306405) | Ain Shams University | 2022-02-20 |
| Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease (NCT05194007) | Mohammed Bin Rashid University of Medicine and Health Sciences | 2022-02-19 |
| Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant (NCT05027906) | Eledon Pharmaceuticals | 2022-02-18 |
| Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) (NCT05250063) | Lumos Pharma | 2022-02-18 |
| INSTI's For The Management of HIV-associated TB (NCT04734652) | Centre for the AIDS Programme of Research in South Africa | 2022-02-18 |
| Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent (NCT05230940) | Health Institutes of Turkey | 2022-02-18 |
| Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic (NCT05415150) | Baylor College of Medicine | 2022-02-18 |
| PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis (NCT04971720) | University of Alabama at Birmingham | 2022-02-18 |
| Zanubrutinib and Venetoclax in CLL (ZANU-VEN) (NCT05168930) | Dana-Farber Cancer Institute | 2022-02-18 |
| Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase) (NCT05203224) | University of Melbourne | 2022-02-18 |
| Study of HA121-28 in Patients With Non-Small Cell Lung Cancer (NCT05117658) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-02-18 |
| Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors (NCT05302921) | Children's National Research Institute | 2022-02-18 |
| Analgesia After Video-Assisted Thoracic Surgery (NCT05094323) | Assiut University | 2022-02-18 |
| Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma (NCT05145400) | UNC Lineberger Comprehensive Cancer Center | 2022-02-18 |
| Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) (NCT05162066) | BioCryst Pharmaceuticals | 2022-02-18 |
| Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer (NCT05150652) | Irada Ibrahim-zada | 2022-02-18 |
| Obinutuzumab in Primary MN (NCT05050214) | Mario Negri Institute for Pharmacological Research | 2022-02-18 |
| Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With Insomnia (NCT05233761) | Defined Research | 2022-02-18 |
| Dose Response Relationship of Oxytocin on Irritability in Youths (NCT03863288) | University of Nebraska | 2022-02-18 |
| Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention (NCT04966507) | University of California, Los Angeles | 2022-02-17 |
| Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer (NCT05017025) | M.D. Anderson Cancer Center | 2022-02-17 |
| Loncastuximab Tesirine in WM (NCT05190705) | Shayna Sarosiek, MD | 2022-02-17 |
| A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer (NCT04917809) | Memorial Sloan Kettering Cancer Center | 2022-02-17 |
| A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG (NCT04270838) | University of Oxford | 2022-02-17 |
| A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies (NCT05269940) | Nanjing Zenshine Pharmaceuticals | 2022-02-17 |
| D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer (NCT05212012) | AIO-Studien-gGmbH | 2022-02-17 |
| The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis (NCT05186922) | Keymed Biosciences Co.Ltd | 2022-02-17 |
| A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration (NCT05230537) | Novartis Pharmaceuticals | 2022-02-17 |